Beneficial effect of recombinant human growth hormone on the intestinal mucosa barrier of septic rats

Brazilian Journal of Medical and Biological Research

Volumn 40, Issue 1, 2007, Pages 41-48

  Yi, C ^a   Cao, Y ^b   Wang, S R ^b   Xu, Y Z ^b   Huang, H ^b   Cui, Y X ^a   Huang, Ying ^b  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Apoptosis; Growth hormone; Insulin like growth factor 1; Intestinal mucosa barrier; Sepsis

Indexed keywords

GROWTH HORMONE; HUMAN GROWTH HORMONE; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2; SODIUM CHLORIDE; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL TRANSLOCATION; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; HISTOPATHOLOGY; INTESTINE MUCOSA; NONHUMAN; PERMEABILITY BARRIER; PROTEIN EXPRESSION; RAT; SEPSIS; TREATMENT OUTCOME;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; RATTUS;

EID: 33846338899     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2007000100006     Document Type: Article

References (21)

1. Scopa CD, Koureleas S, Tsamandas AC, Spiliopoulou I, Alexandrides T, Filos KS, et al. Beneficial effects of growth hormone and insulin-like growth factor 1 on intestinal bacterial translocation, endotoxemia, and apoptosis in experimentally jaundiced rats. J Am Coll Surg 2000; 190: 423-431.
2. Wang X, Wang B, Wu J, Wang G. Beneficial effects of growth hormone on bacterial translocation during the course of acute necrotizing pancreatitis in rats. Pancreas 2001; 23: 148-156.
3. Shulman DI. Gastrointestinal effects of growth hormone. Endocrine 2000; 12: 147-152.
4. Darmaun D, Hayes V, Schaeffer D, Welch S, Mauras N. Effects of glutamine and recombinant human growth hormone on protein metabolism in prepubertal children with cystic fibrosis. J Clin Endocrinol Metab 2004; 89: 1146-1152.
5. Huang Y, Wang SR, Yi C, Ying MY, Lin Y, Zhi MH. Effects of recombinant human growth hormone on rat septic shock with intraabdominal infection by E. coli. World J Gastroenterol 2002; 8: 1134-1137.
6. Sulejczak D, Czarkowska-Bauch J, Macias M, Skup M. Bcl-2 and Bax proteins are increased in neocortical but not in thalamic apoptosis following devascularizing lesion of the cerebral cortex in the rat: an immunohistochemical study. Brain Res 2004; 1006: 133-149.
7. Coopersmith CM, Stromberg PE, Dunne WM, Davis CG, Amiot DM, Buchman TG, et al. Inhibition of intestinal epithelial apoptosis and survival in a murine model of pneumonia-induced sepsis. JAMA 2002; 287: 1716-1721.
8. Baixeras E, Jeay S, Kelly PA, Postel-Vinay MC. The proliferative and antiapoptotic actions of growth hormone and insulin-like growth factor-1 are mediated through distinct signaling pathways in the ProB Ba/F3 celi line. Endocrinology 2001; 142: 2968-2977.
9. Balteskard L, Unneberg K, Mjaaland M, Jenssen TG, Revhaug A. Growth hormone and insulinlike growth factor 1 promote intestinal uptake and hepatic release of glutamine in sepsis. Ann Surg 1998; 228: 131-139.
10. Gelato MC. The growth hormone/insulin-like growth factor axis in critical illness. J Pediatr Endocrinol Metab 2000; 13 (Suppl 2): 1023-1029.
11. Yakar S, Liu JL, Le Roith D. The growth hormone/insulin-like growth factor-1 system: implications for organ growth and development. Pediatr Nephrol 2000; 14: 544-549.
12. Holt RI, Simpson HL, Sonksen PH. The role of the growth hormone-insulin-like growth factor axis in glucose homeostasis. Diabet Med 2003; 20: 3-15.
13. Le Roith D, Scavo L, Butler A. What is the role of circulating IGF-1? Trends Endocrinol Metab 2001; 12: 48-52.
14. Onenli-Mungan N, Yildizdas D, Yapicioglu H, Topaloglu AK, Yuksel B, Ozer G. Growth hormone and insulin-like growth factor 1 levels and their relation to survival in children with bacterial sepsis and septic shock. J Paediatr Child Health 2004; 40: 221-226.
15. Smith JR, Benghuzzi H, Tucci M, Puckett A, Hughes JL. The effects of growth hormone and insulin-like growth factor on the proliferation rate and morphology of RAW 264.7 macrophages. Biomed Sci Instrum 2000; 36: 111-116.
16. Ziegler TR, Mantell MP, Chow JC, Rombeau JL, Smith RJ. Gut adaptation and the insulin-like growth factor system: regulation by glutamine and IGF-1 administration. Am J Physiol 1996; 271: G866-G875.
17. Chen K, Okuma T, Okamura K, Tabira Y, Kaneko H, Miyauchi Y. Insulin-like growth factor-1 prevents gut atrophy and maintains intestinal integrity in septic rats. J Parenter Enteral Nutr 1995; 19: 119-124.
18. Takala J, Ruokonen E, Webster NR, Nielsen MS, Zandstra DF, Vundelinckx G, et al. Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 1999; 341: 785-792.
19. Teng Chung T, Hinds CJ. Treatment with GH and IGF-1 in critical illness. Crit Care Clin 2006; 22: 29-40.
20. Yumet G, Shumate ML, Bryant DP, Lang CH, Cooney RN. Hepatic growth hormone resistance during sepsis is associated with increased suppressors of cytokine signaling expression and impaired growth hormone signaling. Crit Care Med 2006; 34: 1420-1427.
21. Venken K, Schuit F, Van Lommel L, Tsukamoto K, Kopchick JJ, Coschigano K, et al. Growth without growth hormone receptor: estradiol is a major growth hormone-independent regulator of hepatic IGF-1 synthesis. J Bone Miner Res 2005; 20: 2138-2149.